Russian Journal of Infection and Immunity

Aims & Scope

Journal "Infektsiya i immunitet" ("Russian Journal of Infection and Immunity") established by Northwest Branch of RAMS, St.

Petersburg Pasteur Institute and the St.

Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists, with the participation of the St.

Petersburg branch of All-Russian Practical Society of epidemiologists, microbiologists and parasitologists at St.

Petersburg and Leningrad region.

The journal is devoted to numerous aspects of the interaction between different microorganisms and the host organism.

Journal is of interest for microbiologists, immunologists, epidemiologists and clinicians.

The most detailed discussion of the following questions: • molecular basis of infections caused by pathogenic bacteria, fungi and parasites; • mechanisms of pathogenicity of microorganisms; • the impact of microbial virulence factors on host cells; • factors and mechanism to protect the host from infection; • factors of nonspecific and specific immunity; • experimental models of infectious disease; • development of vaccines and nonspecific anti-infectious defense.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology and Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)

  Citation: 84

  Authors: A. B., Е. А., M. P., S. V., E. D., E. A., O. V., O. G., A. S., S. A., G. S., E. S., V. I., N. N., Z. I., V. N., A. A., P. Yu., S. A., T. V., D. V., E. V., R. A.

• History of investigation and current classification of coronaviruses (<i>Nidovirales: Coronaviridae</i>)

  Citation: 63

  Authors: M. Yu., A. Yu., V. G., V. G., V. V.

• COVID-19: etiology, clinical picture, treatment

  Citation: 48

  Authors: M. Yu., L. V., O. A., I. S., V. V.

• Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation

  Citation: 30

  Authors: A. Yu., E. E., E. A., S. V., N. S., M. V., N. N., D. V., N. N., E. B., N. N., O. A., I. V., D. N., S. V., O. P., V. V., A. E., L. A., L. V., A. A., O. M., A. K., L. N., E. E., T. P., M. A., N. A., L. V., V. S., T. F., O. E., Areg A.

• Neutrophil as a multifunctional relay in immune system

  Citation: 24

  Authors: I. I., E A, A Yu, E K

• Innate immunity in coronavirus infection

  Citation: 23

  Authors: V. S., Areg A.

• Methodology for assessing herd immunity to the SARS-CoV-2 virus in the context of the COVID-19 pandemic

  Citation: 22

  Authors: A. Yu., A. A.

• THE NEW LOOK AT NEUTROPHILIC GRANULOCYTES: RETHINKING OLD DOGMAS. PART 1

  Citation: 22

  Authors: I. V., N. V., G. A., L. V., S. V., A. A., T.D. L.

• INFLUENCE OF POPULATION IMMUNITY PECULIARITIES ON THE STRUCTURE OF MEASLES AND RUBELLA PREVALENCE

  Citation: 21

  Authors: A. P., M. A., M. A., N. P., T. A.

• Аntibacterial inorganic agents: efficiency of using multicomponent systems

  Citation: 19

  Authors: А. A., A. G., G. E., A. A., V. P.